Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2023 - 01 - 19 crawled time : 14:20 save search
Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: 3.77%
H: 23.64%
C: 9.09%
bpx-601 pharmaceuticals symposium asco cancer prostate cancer phase 1
New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
NTRA | $89.77 -0.62% 170K
|
Health Services
|
| O: -1.54%
H: 1.59%
C: -1.56%
symposium gastrointestinal asco cancer
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
TWST | $28.685 0.4% 310K
|
Health Technology
|
| O: -2.19%
H: 1.16%
C: -4.03%
report financial bioscience results
Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
NXTC | $1.57 3.97% 28K
|
Health Technology
|
| O: 2.67%
H: 12.99%
C: 11.04%
medical therapeutics
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
SRDX | $26.755 0.89% 8.6K
|
Health Technology
|
| O: -27.61%
H: 15.21%
C: -2.4%
drug conference platform
Teekay Sea Ambassador
Published: 2023-01-19 (Crawled : 14:20) - teekay.com
TNK | $56.14 -2.01% 110K
|
Transportation
|
| O: -0.14%
H: 0.66%
C: 0.45%
TK | $7.16 -0.28% 150K
|
Transportation
|
| O: 0.0%
H: 2.25%
C: 0.9%
Sonnet BioTherapeutics Announces Pharmacokinetic and Pharmacodynamic Data in a Phase 1 Dose-Escalation Trial of SON-1010
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
SONN | $1.7 9.5K
|
Health Technology
|
| O: -3.17%
H: 4.92%
C: -0.41%
son-1010 trial phase 1
SetPoint Medical Announces Expanded $65M Credit Facility to Support Development of the Company’s Novel Platform for Rheumatoid Arthritis
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
RWAY | $12.66 0.64% 93K
|
|
| O: 0.08%
H: 0.0%
C: -1.73%
medical platform
Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal™ blood test to help guide treatment decisions in colorectal cancer
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
GH M | $16.72 2.01% 850K
|
Health Services
|
| O: -1.0%
H: 0.93%
C: -0.03%
treatment blood test health trial trust cancer
Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova Graphene Ballistics, Inc., Releases its Graphene Ballistic Plate Production Approach
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BIEI | News | $0.0013 1.1M
|
Manufacturing
|
| O: 9.52%
H: 0.0%
C: -8.7%
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BSGM | $1.51 -7.36% 320K
|
Health Technology
|
| O: -0.03%
H: 5.63%
C: 4.23%
ongoing update
BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BICX | $1.47 200
|
Health Care and Social Assistan...
|
| O: 3.25%
H: 0.0%
C: 0.0%
bicx104 treatment opioid trial study
ImmunityBio Announces Presentation at ASCO GI 2023 of Fully Enrolled Trial in Third-Line and Greater Pancreatic Cancer and Update on FDA Type B Meetings Regarding Paths to Registration
Published: 2023-01-19 (Crawled : 14:20) - nantkwest.com
IBRX | $5.01 -4.39% 2M
|
Manufacturing
|
| O: -1.1%
H: 1.11%
C: 0.22%
fda trial presentation asco update cancer pancreatic
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
ABVC | News | $0.9863 -3.3% 390K
|
Wholesale Trade
|
| O: 3.29%
H: 5.06%
C: -1.25%
abv-1505 biopharma conference adhd results
Viracta Therapeutics Announces Orphan Drug Designation Granted by the European Commission to Nana-val for the Treatment of Diffuse Large B-cell Lymphoma
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
VIRX | $0.91 -2.8% 71K
|
Manufacturing
|
| O: -1.51%
H: 6.12%
C: 2.55%
treatment designation drug granted therapeutics
Kopin Corporation Provides Restructuring Update
Published: 2023-01-19 (Crawled : 14:20) - kopin.com
KOPN | $1.265 -1.17% 790K
|
Electronic Technology
|
| O: -12.58%
H: 6.47%
C: -10.79%
corporation update
INTRICON NAMES VP OF GLOBAL OPERATIONS
Published: 2023-01-19 (Crawled : 14:20) - intricon.com
IIN | $24.24 0.04% 0.04%
|
Health Technology
| Email alert
Add to watchlist
global
Openmarkets, an Australian Trading and Wealth Management Fintech, Signs Definitive Agreement to Combine with Broad Capital Acquisition Corp. (Nasdaq: BRAC) – Yahoo Finance
Published: 2023-01-19 (Crawled : 14:20) - spacfeed.com
BRAC | News | $11.28 100
|
Finance
|
| O: 0.19%
H: 0.1%
C: 0.0%
acquisition management agreement
Dennis Fehr, Seasoned Financial Executive Joins 6K as Chief Financial Officer and Rob Davies, Manufacturing Expert, Joins 6K Energy as Chief Operating Officer
Published: 2023-01-19 (Crawled : 14:20) - prnewswire.com
CBT | News | $91.485 -0.48% 110K
|
Process Industries
|
| O: -0.69%
H: 0.4%
C: -0.13%
energy financial
Cohen & Company Capital Markets Continues Strong Growth Despite Tumultuous Capital Market Environment – Yahoo Finance
Published: 2023-01-19 (Crawled : 14:20) - spacfeed.com
BRAC | News | $11.28 100
|
Finance
|
| O: 0.19%
H: 0.1%
C: 0.0%
growth market
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.